Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Last Updated: May 19, 2022

CLINICAL TRIALS PROFILE FOR ALITRETINOIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Alitretinoin

Subscribe to access the full database, or Try it Free
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002188 ↗	A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma	Completed	Ligand Pharmaceuticals	Phase 2	1969-12-31	The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).
NCT00002188 ↗	A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma	Completed	Anderson Clinical Research	Phase 2	1969-12-31	The purpose of this study is to see if ALRT1057 is safe and effective in treating patients with AIDS-related Kaposi's sarcoma (KS).
NCT00002439 ↗	A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma	Completed	Ligand Pharmaceuticals	N/A	1969-12-31	The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .
NCT00002439 ↗	A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma	Completed	Anderson Clinical Research	N/A	1969-12-31	The purpose of this study is to see if ALRT1057 gel is safe and effective in treating Kaposi's sarcoma (KS) when applied to skin .
NCT00124436 ↗	Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis	Completed	Basilea Pharmaceutica	Phase 3	2005-03-01	Patients who have been treated in study protocol BAP089 may have responded to treatment, and subsequently relapsed to >75% of the baseline disease severity, will be investigated for response to further treatment with alitretinoin. Also, patients who have responded with mild or moderate disease will be investigated for additional treatment effect after prolongated treatment.
NCT00124475 ↗	Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis	Completed	Basilea Pharmaceutica	Phase 3	2004-12-01	The purpose of the study is to determine the therapeutic effect of alitretinoin, a retinoid, on severe, therapy refractory chronic hand dermatitis.
NCT00309621 ↗	Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis	Completed	Basilea Pharmaceutica	Phase 3	2006-04-01	Patients with severe chronic hand dermatitis, that has not responded to topical treatment, including topical steroids and the avoidance of aggravating factors, will be treated with the oral medication alitretinoin. The study aims to investigate the safety and efficacy of the medication when given over a period of 6 months.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Alitretinoin

Condition Name

Chart
Table

Condition Name for Alitretinoin
Intervention	Trials
Hand Dermatoses	3
Hand Eczema	3
Chronic Hand Eczema	2
Eczema	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Alitretinoin
Intervention	Trials
Eczema	8
Dermatitis	4
Skin Diseases	3
Hand Dermatoses	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Alitretinoin

Trials by Country

Map
Table

Trials by Country for Alitretinoin
Location	Trials
United States	32
Germany	11
Canada	6
Netherlands	4
Denmark	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Alitretinoin
Location	Trials
California	1
New Hampshire	1
District of Columbia	1
Florida	1
Georgia	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Alitretinoin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Alitretinoin
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	9
Phase 2	6
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Alitretinoin
Clinical Trial Phase	Trials
Completed	11
Unknown status	3
Recruiting	3
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Alitretinoin

Sponsor Name

Chart
Table

Sponsor Name for Alitretinoin
Sponsor	Trials
Basilea Pharmaceutica	6
University Medical Center Groningen	3
Ligand Pharmaceuticals	2
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Alitretinoin
Sponsor	Trials
Other	17
Industry	15
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

McKesson

Colorcon

McKinsey

Dow

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.